Related content

Pharmacokinetic behaviour of levodopa and 3-O-methyldopa after repeat administration of levodopa/carbidopa with and without entacapone in patients with Parkinson’s disease

By Müller T.   Erdmann C.   Muhlack S.   Bremen D.   Przuntek H.   Goetze O.   Woitalla D.  

Journal of Neural Transmission, Vol. 113, Iss. 10, 2006-10 ,pp. : 1441-1448

Springer Publishing Company

Access to resources Recommend Favorite

The influence of levodopa-induced dyskinesias on manual tracking in patients with Parkinson’s disease

By Lemieux Sarah   Ghassemi Mehrdad   Jog Mandar   Edwards Roderick   Duval Christian  

Experimental Brain Research, Vol. 176, Iss. 3, 2007-01 ,pp. : 465-475

Springer Publishing Company

Access to resources Recommend Favorite

Levodopa inhibits habit-learning in Parkinson’s disease

By Fuhrer Hannah   Kupsch Andreas   Hälbig Thomas   Kopp Ute   Scherer Peter   Gruber Doreen  

Journal of Neural Transmission, Vol. 121, Iss. 2, 2014-02 ,pp. : 147-151

Springer Publishing Company

Access to resources Recommend Favorite

Entacapone improves the pharmacokinetic and therapeutic response of controlled release levodopa/carbidopa in Parkinson’s patients

By Stocchi F.   Barbato L.   Nordera G.   Bolner A.   Caraceni T.  

Journal of Neural Transmission, Vol. 111, Iss. 2, 2004-02 ,pp. : 173-180

Springer Publishing Company

Access to resources Recommend Favorite

Prospective randomized trial of lisuride infusion versus oral levodopa in patients with Parkinson’s disease

By Stocchi F.  

Brain, Vol. 125, Iss. 9, 2002-09 ,pp. : 2058-2066

Oxford University Press

Access to resources Recommend Favorite